AT
Attovia TherapeuticsAttovia Therapeutics is a clinical-stage biotech developing ATTOBODY-based biotherapeutics for immune-mediated diseases that went public on Nasdaq in August 2026 in an upsized IPO raising ~$332M gross.
8 Pulse stories
TM
Tenon MedicalTenon Medical develops the Catamaran, a minimally invasive titanium implant system for sacroiliac joint fusion to treat lower back pain.
1 Pulse story
Total Raised
~$588M ($256M private + $332M IPO gross incl. greenshoe, Aug 2026)
Attovia TherapeuticsTenon Medical
Last Valuation
$767M at IPO pricing; ~$904M market cap at Nasdaq open (Aug 5, 2026)
Attovia TherapeuticsTenon Medical
Biotech
Sector
Biotech
2023
Founded
2012
San Carlos, CA
HQ
Los Gatos, California
Public (ATTO)
Status
Public (TNON)
Attovia Therapeutics investors
venBio PartnersGoldman Sachs AlternativesFrazier Life SciencesDeep Track CapitalIllumina VenturesSanofi VenturesEcoR1 Capital
Tenon Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Attovia Therapeutics and Tenon Medical.